Related Experiment Video
Updated: Jul 21, 2025
11:08
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
882
Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy
Manuel Scimeca1, Valentina Rovella2, Valeria Palumbo1
1Department of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133 Rome, Italy.
Cancers
|July 29, 2023
Summary
Programmed cell death pathways like apoptosis, ferroptosis, pyroptosis, and necroptosis are crucial in bile duct cancer (cholangiocarcinoma). Targeting these mechanisms may offer new therapeutic strategies for this aggressive disease.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Cholangiocarcinoma (CCA) is an aggressive bile duct cancer with limited treatment options.
- Programmed cell death (PCD) mechanisms, including apoptosis, ferroptosis, pyroptosis, and necroptosis, are increasingly recognized for their roles in cancer.
- Understanding PCD in CCA is vital for developing novel therapeutic strategies.
Purpose of the Study:
- To review the current understanding of programmed cell death's role in cholangiocarcinoma pathogenesis.
- To explore the potential of targeting PCD pathways for novel cholangiocarcinoma therapies.
Main Methods:
- Literature review synthesizing existing research on programmed cell death in cholangiocarcinoma.
- Analysis of studies investigating the involvement of apoptosis, ferroptosis, pyroptosis, and necroptosis in CCA development and progression.
Main Results:
- Dysregulation of apoptosis contributes to cholangiocarcinoma tumorigenesis and treatment resistance.
- Pro-inflammatory cell death pathways (ferroptosis, pyroptosis, necroptosis) can enhance anti-tumor immunity by recruiting and activating immune cells.
- Targeting cell death pathways shows potential to sensitize cholangiocarcinoma cells to chemotherapy and immunotherapy.
Conclusions:
- Programmed cell death is a significant molecular mechanism in cholangiocarcinoma pathogenesis.
- Further research into PCD pathways is necessary to identify effective therapeutic strategies for cholangiocarcinoma.
- Targeting specific cell death modalities offers a promising avenue for future cholangiocarcinoma treatment development.
Keywords:
apoptosischolangiocarcinomaferroptosisnecroptosisprogrammed cell deathpyroptosistargeted therapyMore Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.3K
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
Related Concept Videos
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:31The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
01:30Overview of Cell Death
7.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.4K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
01:27Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558